U.S. FDA Greenlights Pfizer’s Gene Therapy for Hemophilia B
FDA approved Pfizer’s gene therapy targeting hemophilia B, marking a significant stride in the treatment of this rare bleeding disorder.…
FDA approved Pfizer’s gene therapy targeting hemophilia B, marking a significant stride in the treatment of this rare bleeding disorder.…